COVID-19 Infection and Multiple Myeloma (EMN-COVID)
COVID-19 INFECTION IN MULTIPLE MYELOMA PATIENTS: AN EUROPEAN OBSERVATIONAL STUDY
Sponsor: Fondazione EMN Italy Onlus
This observational or N/A phase trial investigates Corona Virus Infection and Covid19 and is currently completed. Fondazione EMN Italy Onlus leads this study, which shows 9 recorded versions since 2020 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
9 versions recorded-
Nov 2024 — Present [monthly]
Completed
-
Sep 2024 — Nov 2024 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2024 — Jul 2024 [monthly]
Completed
Status: Active Not Recruiting → Completed
-
Mar 2024 — Apr 2024 [monthly]
Active Not Recruiting
▶ Show 4 earlier versions
-
Mar 2023 — Mar 2024 [monthly]
Active Not Recruiting
Status: Recruiting → Active Not Recruiting
-
Sep 2021 — Mar 2023 [monthly]
Recruiting
-
Jan 2021 — Sep 2021 [monthly]
Recruiting
-
Aug 2020 — Jan 2021 [monthly]
Recruiting
First recorded
Jul 2020
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione EMN Italy Onlus
- Stichting European Myeloma Network
For direct contact, visit the study record on ClinicalTrials.gov .